Colgate-Palmolive Company (CL) Stock Price Today
Key Stats
- $74.20BMarket Cap
- -Volume
- Consumer StaplesSector
- $99.1452W High
- $74.9852W Low
- -Typical Hold Time
- $80.84BEnterprise Value
- 2.29%Div Yield
- -Trading Activity
Track Colgate-Palmolive Company (CL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Colgate-Palmolive Company has traded between a low of $74.98 and a high of $99.14, highlighting its annual price range. Buy and sell Colgate-Palmolive Company shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Most Recent News
Rentokil shares drop 17% as North America demand weakens and margin target is cut
Rentokil Initial PLC shares fell 17% after the company warned of weaker residential demand in North America and scrapped its 2027 operating margin target of 20%. New CEO Mike Duffy is focusing on investment and volume growth rather than short-term ma...
BlackRock Floating Rate Income Trust yields 13.36% but faces income shortfall risks.
The BlackRock Floating Rate Income Trust (BGT) offers a high yield of 13.36% but is not generating enough income to fully cover its distributions. Its portfolio is heavily invested in speculative-grade senior loans, which increases its exposure to de...
Ademi LLP probes Sanara-MiMedx deal over possible fiduciary breaches and unfair terms.
Ademi LLP is investigating Sanara's recent $350 million transaction with MiMedx for potential breaches of fiduciary duty and other legal violations. The deal offers Sanara shareholders $33 in cash plus MiMedx shares valued at $2 per share, but inside...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.